JCO precision oncology 2019
Immunophenotype and Response to Immunotherapy of RET-Rearranged Lung Cancers.   

Related Questions

Are there scenarios in which you would proceed with checkpoint inhibitor for PDL1+ disease before having full molecular testing results?